112 related articles for article (PubMed ID: 26236663)
1. Experimental Design to Predict Process Variables in the Microcrystals of Celecoxib for Dissolution Rate Enhancement Using Response Surface Methodology.
Jelvehgari M; Valizadeh H; Montazam SH; Abbaszadeh S
Adv Pharm Bull; 2015 Jun; 5(2):237-45. PubMed ID: 26236663
[TBL] [Abstract][Full Text] [Related]
2. Design and characterization of microcrystals for enhanced dissolution rate of celecoxib.
Lakshmi K; Reddy MP; Kaza R
Curr Drug Discov Technol; 2013 Dec; 10(4):305-14. PubMed ID: 24074306
[TBL] [Abstract][Full Text] [Related]
3. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties.
Gupta VR; Mutalik S; Patel MM; Jani GK
Acta Pharm; 2007 Jun; 57(2):173-84. PubMed ID: 17507314
[TBL] [Abstract][Full Text] [Related]
4. Influence of microcrystal formulation on in vivo absorption of celecoxib in rats.
Nasr M
AAPS PharmSciTech; 2013 Jun; 14(2):719-26. PubMed ID: 23543607
[TBL] [Abstract][Full Text] [Related]
5. Process, Physicochemical Characterization and
Kr V; Yalavarthi PR; Vadlamudi HC; Kalluri JKY; Rasheed A
Adv Pharm Bull; 2017 Sep; 7(3):419-425. PubMed ID: 29071224
[No Abstract] [Full Text] [Related]
6. Development of eplerenone nano sono-crystals using factorial design: enhanced solubility and dissolution rate via anti solvent crystallization technique.
Yassin GE; Khalifa MKA
Drug Dev Ind Pharm; 2022 Dec; 48(12):683-693. PubMed ID: 36533708
[TBL] [Abstract][Full Text] [Related]
7. Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer.
Maghsoodi M; Nokhodchi A
Adv Pharm Bull; 2016 Dec; 6(4):607-616. PubMed ID: 28101468
[No Abstract] [Full Text] [Related]
8. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
Dalvadi H; Parmar K; Yadav S
Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
[TBL] [Abstract][Full Text] [Related]
9. Dissolution enhancement of gliclazide using pH change approach in presence of twelve stabilizers with various physico-chemical properties.
Talari R; Varshosaz J; Mostafavi SA; Nokhodchi A
J Pharm Pharm Sci; 2009; 12(3):250-65. PubMed ID: 20067702
[TBL] [Abstract][Full Text] [Related]
10. Design and Development of Crystallo-co-agglomerates of Ritonavir for the Improvement of Physicochemical Properties.
Mahajan NM; Malghade AD; Dumore NG; Thenge RR
Turk J Pharm Sci; 2018 Dec; 15(3):248-255. PubMed ID: 32454667
[TBL] [Abstract][Full Text] [Related]
11. Formulation of cilostazol spherical agglomerates by crystallo-co-agglomeration technique and optimization using design of experimentation.
Deshkar SS; Borde GR; Kale RN; Waghmare BA; Thomas AB
Int J Pharm Investig; 2017; 7(4):164-173. PubMed ID: 29692975
[TBL] [Abstract][Full Text] [Related]
12. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs.
Rasenack N; Hartenhauer H; Müller BW
Int J Pharm; 2003 Mar; 254(2):137-45. PubMed ID: 12623189
[TBL] [Abstract][Full Text] [Related]
13. Solubility Enhancement of Domperidone by Solvent Change
Enteshari S; Varshosaz J
Adv Biomed Res; 2018; 7():109. PubMed ID: 30069440
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
15. Three levels face centered central composite design of colon targeted micro-particulates system of celecoxib: screening of formulations variables and in vivo studies.
Nandy BC; Verma V; Dey S; Mazumder B
Curr Drug Deliv; 2014; 11(5):621-35. PubMed ID: 24844925
[TBL] [Abstract][Full Text] [Related]
16. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
Pandey S; Patil AT
Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
[TBL] [Abstract][Full Text] [Related]
17. Spherical crystallization of celecoxib.
Paradkar AR; Pawar AP; Chordiya JK; Patil VB; Ketkar AR
Drug Dev Ind Pharm; 2002 Nov; 28(10):1213-20. PubMed ID: 12476867
[TBL] [Abstract][Full Text] [Related]
18. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
[TBL] [Abstract][Full Text] [Related]
19. Agglomeration of celecoxib by quasi-emulsion solvent diffusion method without stabilizer: effect of good solvent.
Maghsoodi M; Nokhodchi A
Pharm Dev Technol; 2018 Dec; 23(10):1037-1046. PubMed ID: 27937049
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
